NASDAQ: ADMS       Adamas Pharma
Last Price Today's Change   Day's Range   Trading Volume
2.61   -0.11 (4.04%)  2.54 - 2.76  244,717


Avg Volume (4 weeks):667,989
4 Weeks Range:2.43 - 3.26
4 Weeks Price Volatility (%):
52 Weeks Range:1.90 - 7.78
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Adamas Pharmaceuticals Inc was incorporated in the State of Delaware on November 15, 2000. It is a pharmaceutical company focused on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The Company is developing its wholly-owned product candidate, ADS-5102 (amantadine hydrochloride) for a complication associated with the treatment of Parkinson's disease known as levodopa-induced dyskinesia. The Company's portfolio also includes two drugs commercially available in the United States for indications relating to Alzheimer's disease: Namzaric capsules and Namenda XR extended release capsules.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2281  3545  246  2992 

Top 10 Active Counters
 GNUS 3.57+1.26 
 NIO 9.33+1.42 
 LK 1.38-1.62 
 SOLO 3.25+0.92 
 WKHS 21.10+1.92 
 AAL 12.60-0.21 
 AVP 5.60-0.05 
 PCG 9.571+0.541 
 SQQQ 7.015-0.275 
 GE 6.86+0.12 
Partners & Brokers